For pharma shippers, it is always a crucial question whether to ship their consignments in passive or active containers. While both have their pros and cons, it won't be incorrect to say that passive containers, who are the new entrants, have taken a substantial share of pharmaceutical business from the active containers. In an exclusive interview, Stephen Maietta, head of market development, Envirotainer explains what market segments Envirotainer is focusing at and where the active containers gain an edge over passive containers.
No comments:
Post a Comment